Mandate

Vinge advises Offentliga Hus i Norden AB (publ) in connection with its listing on Nasdaq First North Premier Growth Market

Vinge has advised Offentliga Hus i Norden AB (publ) (“Offentliga Hus”) in connection with its listing on Nasdaq First North Premier Growth Market (“Nasdaq First North Premier”). The prospectus was published on 13 October 2020 and the first day of trading on Nasdaq First North Premier was 23 October 2020.

The price in the offering was SEK 13.40 per share, corresponding to a market value of Offentliga Hus of SEK 3,430 million after the completion of the offering. The offering comprised 111,940,300 shares, of which 55,970,150 shares were newly issued shares and 55,970,150 were existing shares offered by Nordact AB.

Offentliga Hus is a growth-oriented property company with a focus on community service properties, where the tenants are predominantly, directly or indirectly, made up of public sector. The Company is geographically focused on larger and medium-sized cities in Sweden. By offering suitable premises at market conditions, Offentliga Hus are an attractive partner for the state, regions and municipalities in need of long-term and efficient property solutions.

Vinge’s team primarily consisted of David Andersson, William Kåge, Stephanie Stiernstedt and Lorin Arabi (Capital Markets and Public M&A), Maria Schultzberg, Henrik Wastenson and Victor Ericsson (Corporate tax), Mikael Ståhl and Felix Möller (Banking and Finance).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025